Long-term efficacy of trilostene administered twice daily in dogs with pituitary-dependent hyperadrenocorticism

Journal of the American Animal Hospital Association

Volumn 42, Issue 4, 2006, Pages 269-276

  Alenza, Dolores Perez ^a   Arenas, Carolina ^a   Lopez, Mari Luz ^b   Melian, Carlos ^b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Clinica Veterinaria Atlantico   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOCORTICOID; TRILOSTANE;

ANOREXIA; APPETITE DISORDER; ARTICLE; DIARRHEA; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG SAFETY; ELECTROLYTE DISTURBANCE; FEMALE; FOLLOW UP; HYPERADRENOCORTICISM; HYPERKALEMIA; HYPONATREMIA; HYPOPHYSIS; LONG TERM CARE; MALE; NONHUMAN; PROSPECTIVE STUDY; SHIVERING; STATISTICAL ANALYSIS; SURVIVAL; VOMITING; WEAKNESS;

CANIS FAMILIARIS;

EID: 33746136377     PISSN: 15473317     EISSN: 15473317     Source Type: Journal    
DOI: 10.5326/0420269     Document Type: Article

References (22)

1. Feldman EC, Nelson RW. Hyperadrenocorticism (Cushing's syndrome). In: Feldman EC, Nelson RW, eds. Canine and Feline Endocrinology and Reproduction. 3rd ed: Philadelphia: WB Saunders, 2004:252-358.
2. Rijnberk A, Derkinderen PJ, Thijssen JHH. Spontaneous hyperadrenocorticism in the dog. J Endocrinol 1968;41:397-406.
3. Reusch CE. Hyperadrenocorticism. in: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine. 6th ed. Philadelphia: WB Saunders, 2005:1592-1612.
4. Kintzer PP, Peterson ME. Mitotane (o.p'-DDD) treatment of 200 dogs with pituitary-dependent hyperadrenocorticism. J Vet Intern Med 1991;5:182-190.
5. Hertog E, Braakman JCA, Teske E, et al. Results of non-selective adrenocorticolysis by o,p'-DDD in 129 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 1999;144:12-17.
6. Potts GO, Creange JE, Hardong HR, et al. Trilostane, an orally active inhibitor of steroid biosynthesis. Steroids 1978;32:257-267.
7. Winterberg B, Vetter W, Groth H, et al. Primary aldosteronism: treatment with trilostane. Cardiology 1985;77:117-121.
8. Wenger M, Ruckstuhl NS, Reusch CE. Effect of trilostane on serum concentrations of aldosterone, cortisol, and potassium in dogs with pituitary-dependent hyperadrenocolticism. Am J Vet Res 2004;65:1245-1250.
9. Neiger R, Ramsey I, O'Connor J, et al. Trilostane treatment of 78 dogs with pituitary-dependent hyperadrenocorticism. Vet Rec 2002;150:799-804.
10. Ruckstuhl NS, Nett CS, Reusch CE. Results of clinical examinations, laboratory tests, and ultrasonography in dogs with pituitary-dependent hyperadrenocorticism treated with trilostane. Am J Vet Res 2002;63:506-512.
11. Braddock JA, Church DB, Robertson ID, et al. Trilostane treatment in dogs with pituitary-dependent hyperadrenocorticism. Aust Vet J 2003;81-.600-607.
12. Eastwood JM, Elwood CM, Hurley KJ. Trilostane treatment of a dog with functional adrenocortical neoplasia. J Small Anim Pract 2003;44:126-131.
13. Eastwood JM, Elwood CM, Hurley KJ. Trilostane treatment of four dogs with functional adrenocortical neoplasia [abstract]. Proceed 11th Eur Soc Vet Intern Med Congress, Dublin, 2001:185.
14. Hurley K, Sturgess K, Cauvin A, et al. The use of trilostane for the treatment of hyperadrenocorticism. in dogs [abstract]. J Vet Intern Med 1998;12:210.
15. Neiger R, Ramsey I. Trilostane therapy of canine hyperadrenocorticism. Proceed 20th Am Coll Vet Intern Med Forum, Dallas, 2002:544-546.
16. Robinson DT, Earnshaw RJ, Mitchell R, et al. The bioavailability and metabolism of trilostane in normal subjects, a comparative study using high pressure liquid chromatographic and quantitative cytochemical assays. J Steroid Biochem 1984;21:601-605.
17. McGee JP, Palin JK, Shaw PN, et al. High performance liquid chromatographic analysis of trilostane and ketotrilostane in rat plasma. J Chromatogr 1991;567:282-287.
18. Neiger IA, Hurley K. 24 hour cortisol values in dogs with hyperadrenocorticism on trilostane. Proceed British Small Anim Vet Assoc Congress, Birmingham, 2001:549.
19. Behrend EN, Clark TP, Kemppainen RJ. Efficacy of and side effects associated with use of ketoconazole as treatment of canine Cushing's syndrome [abstract]. J Vet Intern Med 1996;10:182.
20. Ramsey I, Mc Grotty Y. The effect of trilostane on ACTH stimulation test performed at two different times post treatment. Proceed 11th Eur Soc Vet Intern Med Congress, Dublin, 2001:184-185.
21. Eastwood JM, Elwood CM. Prolonged hypoadrenocorticism in five dogs treated with trilostane for pituitary dependent hyperadrenocorticism (PDH). Proceed British Small Anim Vet Assoc Congress, Edinburgh, 2003:527.
22. Chapman PS, Kellys DF, Archer J, et al. Adrenal necrosis in a dog receiving trilostane for the treatment of hyperadrenocorticism. J Small Anim Pract 2004;45:307-310.